FADS1 serves as a candidate shared biomarker for metabolic dysfunction‑associated steatohepatitis related early‑onset colorectal cancer identified via machine learning and in vitro validation

Abstract Newest evidence shows a link between early-onset colorectal cancer (EO-CRC) and metabolic dysfunction-associated steatohepatitis (MASH). The molecular mechanism behind this connection is not clear. This study tries to find key biomarkers linked to the progression and treatment response of MASH-associated EO-CRC. Differential expression analysis (DEGs) and weighted gene co-expression network analysis (WGCNA) were performed to mine associated genes. Forty-four machine learning algorithms were used to screen candidate biomarkers. For the purpose of pinpointing critical biomarkers, this study, integrating survival analysis, expression profiling, and prognostic assessment, was carried out. Through the application of single-cell RNA sequencing (scRNA-seq) data and in vitro experimental approaches, verification, of gene expression and functional roles, was achieved. With the edgeR package and WGCNA, coexpressed genes enriched in matrix remodeling and lipid metabolism pathways are obtained, and seven candidate biomarkers are selected by machine learning, among which only FADS1 connects to disease prognosis and advanced stage. scRNA-seq and virtual knockout experiments revealed that FADS1 in tumor cells is associated with fibrosis and angiogenesis. Further validation using quantitative real-time PCR (qRT-PCR), Western blotting and immunohistochemistry (IHC) staining identified FADS1 as a candidate shared biomarker, offering a promising theoretical basis for fundamental tumor research and clinical translational applications.

Authors

Institutions

Publication Details

Journal
Discover Oncology
Published
2026-11-15
DOI
https://doi.org/10.1007/s12672-026-06235-y
Primary Topic
Colorectal Cancer Treatments and Studies
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

FADS1 serves as a candidate shared biomarker for metabolic dysfunction‑associated steatohepatitis related early‑onset colorectal cancer identified via machine learning and in vitro validation

Yingdong Hou, Xuepei Zhang, Yifeng Zhou, Xiangyun He et al.
Discover Oncology
Colorectal Cancer Treatments and Studies
article

FADS1 serves as a candidate shared biomarker for metabolic dysfunction‑associated steatohepatitis related early‑onset colorectal cancer identified via machine learning and in vitro validation

Yingdong Hou, Xuepei Zhang, Yifeng Zhou, Xiangyun He, Hubin Xia, Qianli Yu
article en

Abstract

Abstract Newest evidence shows a link between early-onset colorectal cancer (EO-CRC) and metabolic dysfunction-associated steatohepatitis (MASH). The molecular mechanism behind this connection is not clear. This study tries to find key biomarkers linked to the progression and treatment response of MASH-associated EO-CRC. Differential expression analysis (DEGs) and weighted gene co-expression network analysis (WGCNA) were performed to mine associated genes. Forty-four machine learning algorithms were used to screen candidate biomarkers. For the purpose of pinpointing critical biomarkers, this study, integrating survival analysis, expression profiling, and prognostic assessment, was carried out. Through the application of single-cell RNA sequencing (scRNA-seq) data and in vitro experimental approaches, verification, of gene expression and functional roles, was achieved. With the edgeR package and WGCNA, coexpressed genes enriched in matrix remodeling and lipid metabolism pathways are obtained, and seven candidate biomarkers are selected by machine learning, among which only FADS1 connects to disease prognosis and advanced stage. scRNA-seq and virtual knockout experiments revealed that FADS1 in tumor cells is associated with fibrosis and angiogenesis. Further validation using quantitative real-time PCR (qRT-PCR), Western blotting and immunohistochemistry (IHC) staining identified FADS1 as a candidate shared biomarker, offering a promising theoretical basis for fundamental tumor research and clinical translational applications.

Discover Oncology
Zhejiang Chinese Medical University (CN), Westlake University (CN), Zhejiang Cancer Hospital (CN), Affiliated Hangzhou First People's Hospital, Westlake University, School of Medicine (CN)
Colorectal Cancer Treatments and Studies
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon